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Introduction: During surgical resection of a peripherally located 
high-grade neuroendocrine carcinoma (HGNEC), we unexpectedly 
discovered prominent bronchial intraepithelial tumor spread up to the 
surgical end of the bronchus. Because bronchial intraepithelial tumor 
spread of peripherally located HGNEC has been rarely reported, we 
conducted a retrospective analysis at our hospital.
Methods: We histologically reviewed surgically resected HGNEC 
cases to assess bronchial intraepithelial spread of tumor cells. 
HGNECs with bronchial intraepithelial tumor spread were further 
studied by immunohistochemistry for neuroendocrine markers, and 
their clinicopathological characteristics were evaluated.
Results: Of 1778 cases of surgically resected lung cancer in our 
hospital, 47 cases of HGNEC were evaluated. Bronchial intraepi-
thelial tumor spread was observed in nine cases (19.1%); eight of 
these cases were large-cell neuroendocrine carcinoma (LCNEC) or 
small-cell lung carcinoma with an LCNEC component. Moreover, 
bronchial intraepithelial tumor spread was continuous from the pri-
mary tumor to the resected end of the bronchus in four cases, and all 
these cases had an LCNEC component. Furthermore, HGNEC with 
bronchial intraepithelial tumor spread was associated with a higher 
recurrence rate than no bronchial intraepithelial tumor spread.
Conclusion: The results of this study suggest that bronchial intraepi-
thelial tumor spread is commonly observed in cases of peripherally 
located HGNEC and may be a unique form of tumor invasion, espe-
cially tumors with LCNEC morphology. Therefore, surgeons and 
pathologists should be cognizant of bronchial intraepithelial tumor 
spread in peripherally located HGNEC, as well as its potential role as 
an indicator of HGNEC aggressiveness.
Key Words: High-grade neuroendocrine carcinoma, Large-cell 
neuroendocrine carcinoma, Bronchial intraepithelial tumor spread, 
Bronchus.
(J Thorac Oncol. 2015;10: 1337–1340)
Both small-cell lung carcinoma (SCLC) and large-cell neuroendocrine carcinoma (LCNEC) are classified as 
high-grade neuroendocrine carcinoma (HGNEC).1,2 Centrally 
located SCLC usually involves tumor cells that invade along 
the bronchial mucosa.3 However, bronchial intraepithelial 
tumor spread of peripherally located HGNEC has been rarely 
reported.
In our hospital, during the surgical resection of a periph-
erally located HGNEC, we unexpectedly discovered tumor 
spread along the bronchial epithelium up to the surgical end 
of the bronchus. Prompted by our experience with this inter-
esting case, we histologically reviewed other cases of HGNEC 
to evaluate bronchial intraepithelial spread of tumor cells 
to determine the frequency and characteristics of this rare 
presentation.
PATIENTS AND METHODS
Between September 2002 and December 2012, 1778 
patients underwent surgical resection for primary lung cancer 
at the Shizuoka Cancer Center Hospital in Shizuoka, Japan. Of 
these, 67 (3.8%) patients had tumors that were pathologically 
diagnosed as HGNEC, either SCLC or LCNEC. We histologi-
cally reviewed 47 cases of HGNEC in patients who underwent 
segmentectomy, lobectomy, or pneumonectomy with lymph 
node dissection; our focus was on the potential bronchial 
intraepithelial spread of tumor cells. Bronchial intraepithelial 
tumor spread was defined as continuous tumor invasion into the 
bronchus or bronchiole located outside the main tumor mass, 
and we excluded any tumor cell invasion of the bronchial lamina 
propria and submucosa or along the peribronchial soft tissue.
The histologic diagnoses of SCLC and LCNEC were 
based on the revised World Health Organization classification 
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of lung carcinoma (2004).2 Immunohistochemical analysis 
using CD56 antibodies (Nihonkayaku, Tokyo, Japan), chro-
mogranin A (Dako, Glostrup, Denmark), and synaptophysin 
antibodies (Leica Microsystems, Newcastle, United Kingdom) 
was performed on paraffin-embedded tissue samples from all 
patients to confirm the neuroendocrine phenotype.
To analyze the clinicopathological characteristics of 
HGNEC, clinical and pathological information was collected 
from the medical records. This study was approved by the 
Shizuoka Cancer Center Institutional review Board.
The clinicopathological features of patients were com-
pared using the Fisher’s exact test or the chi-square test. 
A p value of less than 0.05 was considered statistically sig-
nificant. All statistical analyses were performed using JMP 9 
software (SAS Institute, Cary, NC).
RESULTS
A Representative Case
Herein, we describe the details of the case that prompted 
us to perform this study, as a representative case. The patient 
was a 66-year-old man who was admitted to our hospital with 
an abnormal shadow on a chest radiograph. Chest computed 
tomography revealed a well-defined and lobulated solid nod-
ule measuring 2.4 cm in diameter in the left peripheral S1+2b 
segment (Fig. 1). Transbronchial lung cytology yielded a path-
ological diagnosis of non-SCLC, and bronchoscopy showed 
normal epithelium of the B1+2 bronchus and the left upper 
bronchus. The clinical stage was T1bN0M0 (stage IA), and 
a left upper lobectomy was performed. The resected tumor 
was 1.6 × 1.5 × 1.5 cm. Microscopically, the tumor contained 
a vast necrotic area in the center and variably sized tumor 
nests around the necrotic area (Fig. 2A). Tumor nests were a 
mix of small cells with fine hyperchromatic oval- to spindle-
shaped nuclei and large cells with large round nuclei, distinct 
nucleoli, and scant cytoplasm (Fig. 2B). The tumor cell bor-
der was clear, and many rosette-like structures were observed. 
Immunohistochemical analysis revealed that the cells were 
diffusely positive for CD56 (Fig. 2B, inset), partially positive 
FIGURE 1.  Radiographic findings of the tumor: Computed 
tomography of the chest reveals a well-defined and lobulated 
solid nodule measuring 2.4 cm in diameter in the left periph-
eral S1+2b segment.
FIGURE 2.  Microscopic findings of 
high-grade neuroendocrine carci-
noma: The tumor has a vast necrotic 
area in the center (right side) and 
variably sized tumor nests around 
the necrotic area. Bronchiole is 
completely replaced by tumor cells 
(single arrow) and vascular invasion 
is seen in the center (A). The tumor 
nests are a mix of small cells (single 
arrow) with fine hyperchromatic 
oval- to spindle-shaped nuclei and 
large cells (double arrows) with 
large round nuclei, small nucleoli, 
and scant cytoplasm (B). The tumor 
cells are positive for CD56 (B, inset). 
Apart from the primary tumor, the 
bronchial epithelium and bronchial 
glands in the B1+2b region have tumor 
cell invasion (C). Two to three layers 
of tumor cells occupying the basal 
bronchial epithelium and normal 
respiratory epithelial cells are present 
on the surface at the resected end of 
the left upper bronchus (D).
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for chromogranin A, and negative for synaptophysin. The final 
pathological diagnosis was SCLC combined with LCNEC, 
and the pathological stage was T1aN0M0 (stage IA).
There was a peripheral B1+2b bronchiole within the pri-
mary tumor, and the mucosal epithelium of the bronchiole was 
completely damaged and replaced by tumor cells. Apart from the 
primary tumor, tumor cell invasion was seen in the bronchial epi-
thelium and bronchial glands in the B1+2b region (Fig. 2C), but cil-
iated epithelium remained on the invading tumor cells. Moreover, 
tumor cells had invaded the epithelium of the B1+2 bronchus and 
the resected end of the left upper bronchus. Approximately 10% 
of the circumference of the left upper lobe bronchial resection 
margin showed two to three layers of tumor cells under the cili-
ated bronchial epithelium (Fig. 2D). Bronchial glands were not 
involved. The degree of bronchial intraepithelial tumor cell inva-
sion decreased with increasing distance from the primary tumor. 
Immunohistochemistry revealed the same staining pattern in the 
bronchial intraepithelial tumor cells as in the primary tumor.
Cases of High-Grade Neuroendocrine 
Carcinoma with Bronchial 
Intraepithelial Tumor Spread
Of the 47 cases of surgically resected HGNEC, nine 
(19.1%) had bronchial intraepithelial spread of tumor cells. 
The clinicopathological characteristics of these nine patients 
are summarized in Table 1.
Of these nine cases, four were pure LCNEC (Fig. 3), 
three were SCLC combined with LCNEC, one was pure 
SCLC, and one was LCNEC combined with adenocarcinoma. 
Moreover, in four of these cases, bronchial intraepithelial 
tumor spread was found not only around the primary tumor but 
also up to the resected end of the bronchus. All of these four 
cases involved an LCNEC component. In all cases except one, 
the tumor recurred after surgery. Five of the nine patients with 
bronchial intraepithelial spread died of their disease (Table 1).
Comparison of High-Grade Neuroendocrine 
Carcinoma Cases with and without 
Bronchial Intraepithelial Tumor Spread
The age range of the 47 patients (34 men and 13 
women) with HGNEC was 51 to 82 years (median, 70 years). 
The results of the comparative study of clinicopathological 
features of HGNEC with or without bronchial intraepithelial 
tumor spread are shown in Table 2. Statistical analysis showed 
no significant differences in the clinicopathological features 
between HGNEC with or without bronchial intraepithelial 
tumor spread, except for the recurrence rate, which was higher 
in cases of HGNEC with bronchial intraepithelial tumor 
TABLE 1.  Clinicopathological Summary of High-Grade Neuroendocrine Carcinoma Cases with Bronchial Intraepithelial Spread
Case Sex Age (yr) p-Stage
Histologic 
Type CD56 Synaptophysin Chromo-A
Resected 
End of the 
Bronchus Outcome (mo)
1 M 66 IA SCLC + 
LCNEC
+ − + Positive ANrD (24)
2 M 73 IB LCNEC + + + Positive DOD (14)
3 M 63 IB LCNEC + AD + − − Positive ArD (31)
4 M 71 IIIA LCNEC + + − Positive DOD (30)
5 M 82 IB LCNEC + + + Negative DOD (42)
6 M 68 IIA LCNEC + − − Negative DOD (65)
7 M 75 IIA SCLC + + + Negative ArD (14)
8 M 71 IIA SCLC + 
LCNEC
+ + − Negative DOD (7)
9 F 68 IIIA SCLC + 
LCNEC
+ − − Negative ArD (26)
AD, adenocarcinoma; ANrD, alive with no recurrent disease; ArD, alive with recurrent disease; Chromo-A, chromogranin A; DOD, died of the disease; LCNEC, large-cell 
neuroendocrine carcinoma; SCLC, small-cell lung carcinoma.
FIGURE 3.  Microscopic findings of 
large-cell neuroendocrine carcinoma 
with bronchial intraepithelial spread 
(case 4 in Table 1): The primary 
tumor, composed of large polygonal 
cells, shows prominent rosette-like 
structures with massive necrosis (A). 
Outside the primary tumor, tumor 
cells invade the bronchial epithelium 
(B); tumor cells are immunohisto-
chemically positive for CD56 (B, 
inset).
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spread than in cases of HGNEC without bronchial intraepithe-
lial tumor spread (88.9% versus 44.7%, p = 0.03). Although 
tumor cell invasion was observed at the surgical end of the 
bronchus in four HGNEC cases with bronchial intraepithelial 
tumor spread, no tumor cell invasion was seen at the resected 
end of the bronchus in HGNEC cases without bronchial 
intraepithelial tumor spread.
DISCUSSION
Among lung cancers, it is well known that centrally 
located squamous cell carcinoma frequently shows bronchial 
intraepithelial (in situ) spread as one of the major patterns of 
tumor spread. In SCLC, tumor cell spread is known to occur 
along peribronchial lymphatic tissues or around bronchovascu-
lar bundles. However, bronchial intraepithelial spread of tumor 
cells is very rarely reported in HGNEC. Until now, only two 
articles have described bronchial intraepithelial tumor spread 
associated with invasive SCLC.4,5 Nicholson et al.4 studied 100 
cases of surgically resected SCLC and found four cases of pag-
etoid tumor cell spread undermining the normal respiratory 
epithelium. They described these lesions as preinvasive lesions, 
but did not focus on this phenomenon in detail. recently, rosen 
and Nicole5 reported a case of SCLC with marked bronchial 
epithelial involvement. Interestingly, their case was not of a 
pure SCLC, but rather there was an LCNEC component. This 
finding is in accordance with the results of our study of HGNEC 
with bronchial intraepithelial tumor spread. rosen and Nicole 
concluded that the bronchial intraepithelial lesion was a pre-
cursor lesion of SCLC, and they stressed the need for further 
comprehensive study of the structure and immunophenotype of 
bronchial mucosal abnormalities associated with SCLC.
Although these previous studies have concluded that 
bronchial intraepithelial lesions are preinvasive or precur-
sor lesions of SCLC, we consider that intraepithelial lesions 
represent a unique form of tumor invasion in HGNEC for 
the following reasons. First, the intraepithelial tumor spread 
extended along the bronchial mucosa, including the bronchial 
gland, and reached the resected end of the bronchus in four 
cases. Second, the degree of bronchial intraepithelial spread 
decreased according to the distance from the primary tumor. 
Third, HGNEC with bronchial intraepithelial tumor spread 
had a high recurrence rate, suggesting that it has a high malig-
nant potential. Finally, HGNEC with bronchial intraepithelial 
tumor spread was closely related to the structure of LCNEC.
To the best of our knowledge, this is the first compre-
hensive study about bronchial intraepithelial tumor spread as 
a way of tumor progression in peripherally located HGNEC, 
especially in tumors with LCNEC structure. Therefore, we 
hypothesized that LCNEC cells might have biological charac-
teristics of bronchial epithelial cells.
It would have been difficult to predict the bronchial 
intraepithelial tumor spread preoperatively, because there were 
no significant differences in clinical factors (e.g., age, tumor 
size, and tumor markers) between patients with or without 
bronchial intraepithelial tumor spread. Bronchoscopy would 
not have helped detect this lesion, because the ciliated respi-
ratory epithelium covered the tumor cells. Therefore, during 
surgery of peripherally located HGNEC, we decided to submit 
the resected end of the bronchus to the intraoperative diagnosis. 
If we find the bronchial intraepithelial spread in the resected 
end of the bronchus, we consider a larger anatomical resection 
such as sleeve lobectomy. As surgeons and pathologists may 
generally be unaware of this phenomenon as an indicator of the 
aggressiveness of peripherally located HGNEC, further studies 
and case analysis are necessary to verify this unique pathologi-
cal observation and establish widespread awareness of it.
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TABLE 2.  Clinicopathological Features of High-Grade 
Neuroendocrine Carcinoma Cases with or without BIS
Variables With BIS Without BIS p Value
No. of patients 9 38
Sex, n (%)
 Male 8 (89) 26 (68) 0.41
 Female 1 (11) 12 (32)
Age (yr)
 Median 71 70 0.41
 range 63–82 51–79
Smoking history, n (%) 9 (100) 37 (97) 1.00
Abnormal increase of serum tumor marker, n (%)
 CEA (ng/ml) 3 (33) 23 (61) 0.26
 NSE (ng/ml) 2 (22) 11 (29) 1.00
 ProGrP (pg/ml) 1 (11) 8 (21) 0.67
Tumor size (cm)
 Median 3.5 2.8 0.11
 range 1.7–8.0 1.2–6.8
Pathological nodal status, n (%)
 Pathological N0 4 (44) 26 (68) 0.25
 Pathological N1–N2 5 (56) 12 (32)
Surgical procedure, n (%)
 Segmentectomy 0 (0) 3 (8) 1.00
 Lobectomy or more 9 (100) 35 (92)
Histologic type, n (%)
 LCNEC 5 (56) 19 (50) 1.00
 SCLC 4 (44) 19 (50)
recurrence, n (%) 8 (89) 17 (45) 0.03
BIS, bronchial intraepithelial spread; CEA, carcinoembryonic antigen; LCNEC, 
large-cell neuroendocrine carcinoma; NSE, neuron-specific enolase; ProGrP, progastrin-
releasing peptide; SCLC, small-cell lung carcinoma.
